×

Cyr61 as a Biomarker for Diagnosis and Prognosis of Cancers of Epithelial Origin

  • US 20080286811A1
  • Filed: 02/17/2006
  • Published: 11/20/2008
  • Est. Priority Date: 02/18/2005
  • Status: Active Grant
First Claim
Patent Images

1. A method for facilitating the diagnosis of a subject for a cancer of epithelial origin comprising:

  • a. measuring Cyr61 levels present in a test urine sample obtained from the subject;

    b. comparing the level of Cyr61 in the test urine sample with the level of Cyr61 present in a control urine sample;

    wherein a higher level of Cyr61 in the test sample as compared to the level of Cyr61 in the control sample is indicative of cancer of epithelial origin.

View all claims
  • 1 Assignment
Timeline View
Assignment View
    ×
    ×